Vertex Pharmaceuticals (VRTX) Shares Outstanding (Diluted) (2009 - 2026)

Vertex Pharmaceuticals (VRTX) Shares Outstanding (Diluted) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 255.20 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 106.00 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 64.41 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 210.89 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.51 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 25.05 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 556.90 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 138.28 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 217.35 Mn
10 Roivant Sciences 26.16 Bn 26.85 Bn 1.16 Mn 720.78 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 255.20 Mn
Mar 31, 2026 256.30 Mn
Dec 31, 2025 258.00 Mn
Sep 30, 2025 257.60 Mn
Jun 30, 2025 258.90 Mn
Mar 31, 2025 259.50 Mn
Dec 31, 2024 257.90 Mn
Sep 30, 2024 261.00 Mn
Jun 30, 2024 258.10 Mn
Mar 31, 2024 261.10 Mn
Dec 31, 2023 260.50 Mn
Sep 30, 2023 260.60 Mn
Jun 30, 2023 260.40 Mn
Mar 31, 2023 260.30 Mn
Dec 31, 2022 259.10 Mn
Sep 30, 2022 259.50 Mn
Jun 30, 2022 258.70 Mn
Mar 31, 2022 257.90 Mn
Dec 31, 2021 259.90 Mn
Sep 30, 2021 259.71 Mn